MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): An Update on Recruitment

    R. Schneider, L. Omberg, T. Myers, S. Anthwal, E. Kayson, C. Tarolli, M. Daeschler, E. Macklin, E. Dorsey, L. Mangravite, M. Schwarzschild, T. Simuni (Chicago, IL, USA)

    Objective: To leverage technology to develop a new model for the long-term follow-up of Parkinson’s disease (PD) clinical trial cohorts and investigate novel disease measures.…
  • 2019 International Congress

    Increased lysosphingolipids levels in blood of patients with multiple system atrophy

    K. Senkevich, G. Baydakova, A. Emelyanov, M. Nikolaev, A. Kopytova, I. Miliukhina, E. Gracheva, A. Kudrevatykh, I. Krasakov, L. Khublarova, I. Fursova, Y. Irishina, N. Zalutskaya, Y. Beltseva, E. Zakharova, S. Pchelina (Saint-Petersburg, Russian Federation)

    Objective: To estimate activity of lysosomal enzymes and lysosphingolipids concentration in dry blood spot of patients with synuleinopathies: Parkinson’s disease (PD), dementia with Lewy bodies…
  • 2019 International Congress

    Early diagnosis of progressive supranuclear palsy using quantitative MRI analysis of brain structure

    K. Seo, T. Yamamoto, H. Kawasaki, T. Hukuoka, Y. Nakazato, K. Takahashi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We examined whetherquantitative MRI analysis of brain structure was useful for early diagnosis of PSP. Background: Quantitative analysis of brain structure by means of…
  • 2019 International Congress

    Prevalence of Parkinson’s disease and parkinsonism in Kyrgyzstan

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: Aim of the study is to determine frequency and overall picture of disease characteristics, evaluation and treatment of patients with Parkinson’s disease (PD) and…
  • 2019 International Congress

    Protective effects of β-Nicotinamide Adenine Dinucleotide against motor deficits and dopaminergic neuronal damage in a Parkinson’s disease mouse model

    C. Shan, YL. Gong, QQ. Zhuang, YF. Hou, SM. Wang, ST. Li, JM. Liu (Shanghai, China)

    Objective: The aim of our study is to explore whether nicotinamide adenine dinucleotide (NAD) replenishment could be beneficial on a 6-hydroxydopamine-induced Parkinson’s disease (PD) mouse…
  • 2019 International Congress

    BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

    Y. Shen, J. Wang, K. Zhang (Nanjing, China)

    Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…
  • 2019 International Congress

    Concentration of short chain fatty acids in the peripheral blood of patients with Parkinson disease

    C. Shin, Y. Lim, TB. Ahn (Seoul, Republic of Korea)

    Objective: Based on the possible role of short chain fatty acids (SCFAs) on the permeability of the blood-brain barrier and its change in Parkinson disease…
  • 2019 International Congress

    The frequency and impact of mutations in the GBA gene and APOε4 polymorphisms on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

    T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, R. Shahar, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)

    Objective: We aimed to explore the frequency and clinical impact of GBA mutations and APOε4 polymorphisms in a cohort of Ashkenazi Jewish (AJ) patients with…
  • 2019 International Congress

    Examining level of hemoglobin in patients with parkinson’s disease and the role of hemoglobin level in the disease course

    SH. Shohimardonov, K. Daminova (Tashkent, Uzbekistan)

    Objective: 1. Is there a correlation between the concentration of hemoglobin in the blood and the development of Parkinson's disease? 2. Does the high level…
  • 2019 International Congress

    Resting-state EEG functional connectivity in Parkinson’s disease

    R. Shoorangiz, E. Peterson, R. Jones, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine EEG functional connectivity (FC) between brain regions during resting wakefulness as a function of cognitive status in PD. Background: Progressive cognitive decline…
  • « Previous Page
  • 1
  • …
  • 1298
  • 1299
  • 1300
  • 1301
  • 1302
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley